GILL SIMBA 4
4 · Evelo Biosciences, Inc. · Filed May 9, 2023
Insider Transaction Report
Form 4
GILL SIMBA
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2023-05-07+23,437→ 62,049 total - Exercise/Conversion
Restricted Stock Units
2023-05-07+23,437→ 351,563 total→ Common Stock (23,437 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date.